(Q41375331)

30 September 2017

Association between IL28B polymorphism, TNFα and biomarkers of insulin resistance in chronic hepatitis C-related insulin resistance (English)

1 reference

30 September 2017

0 references

1 reference

Jean-Michel Pawlotsky

7

1 reference

30 September 2017

M Lemoine

1

1 reference

30 September 2017

S Chevaliez

2

1 reference

30 September 2017

J P Bastard

3

1 reference

30 September 2017

L Fartoux

4

1 reference

30 September 2017

O Chazouillères

5

1 reference

30 September 2017

J Capeau

6

1 reference

30 September 2017

L Serfaty

8

1 reference

30 September 2017

language of work or name

1 reference

26 March 2015

1 reference

Journal of Viral Hepatitis

30 September 2017

1 reference

30 September 2017

22

1 reference

30 September 2017

11

1 reference

30 September 2017

890-896

1 reference

Hepatitis C, insulin resistance and diabetes: clinical and pathogenic data

30 September 2017

1 reference

Abnormalities of lipid metabolism in hepatitis C virus infection

21 January 2018

1 reference

Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis

21 January 2018

1 reference

Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States

21 January 2018

1 reference

Impact of insulin resistance on sustained response in HCV patients treated with pegylated interferon and ribavirin: a meta-analysis.

21 January 2018

1 reference

Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance

21 January 2018

1 reference

Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients.

21 January 2018

1 reference

Sustained virological response prevents the development of insulin resistance in patients with chronic hepatitis C.

21 January 2018

1 reference

Reduction of insulin resistance with effective clearance of hepatitis C infection: results from the HALT-C trial

21 January 2018

1 reference

Sustained virological response correlates with reduction in the incidence of glucose abnormalities in patients with chronic hepatitis C virus infection.

21 January 2018

1 reference

Clearance of HCV improves insulin resistance, beta-cell function, and hepatic expression of insulin receptor substrate 1 and 2.

21 January 2018

1 reference

Interleukin-28B polymorphism improves viral kinetics and is the strongest pretreatment predictor of sustained virologic response in genotype 1 hepatitis C virus

21 January 2018

1 reference

Interferon-lambda genotype and low serum low-density lipoprotein cholesterol levels in patients with chronic hepatitis C infection.

21 January 2018

1 reference

Relation of IL28B gene polymorphism with biochemical and histological features in hepatitis C virus-induced liver disease

21 January 2018

1 reference

Role of interleukin 28B rs12979860 C/T polymorphism on the histological outcome of chronic hepatitis C: relationship with gender and viral genotype.

21 January 2018

1 reference

The outcomes of glucose abnormalities in pre-diabetic chronic hepatitis C patients receiving peginterferon plus ribavirin therapy.

21 January 2018

1 reference

Association of the IL28B genotype with insulin resistance in patients with chronic hepatitis C.

21 January 2018

1 reference

Effects of IL28B rs12979860 CC genotype on metabolic profile and sustained virologic response in patients with genotype 1 chronic hepatitis C.

21 January 2018

1 reference

The assessment of insulin resistance in man.

21 January 2018

1 reference

An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group

21 January 2018

1 reference

High-dose pegylated interferon-α and ribavirin in nonresponder hepatitis C patients and relationship with IL-28B genotype (SYREN trial).

21 January 2018

1 reference

Genotype-specific interactions of insulin resistance, steatosis, and fibrosis in chronic hepatitis C.

21 January 2018

1 reference

Insulin resistance undermines the advantages of IL28B polymorphism in the pegylated interferon alpha-2b and ribavirin treatment of chronic hepatitis C patients with genotype 1.

21 January 2018

1 reference

Interleukin 28B genotype and insulin resistance in chronic hepatitis C patients

21 January 2018

1 reference

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

Serum adipokine levels predictive of liver injury in non-alcoholic fatty liver disease.

21 January 2018

1 reference

Different cytokine profiles of intraphepatic T cells in chronic hepatitis B and hepatitis C virus infections.

21 January 2018

1 reference

Clinical utility of total HCV core antigen quantification: a new indirect marker of HCV replication

21 January 2018

1 reference

Beneficial IL28B genotype associated with lower frequency of hepatic steatosis in patients with chronic hepatitis C

21 January 2018

1 reference

Common variation of IL28 affects gamma-GTP levels and inflammation of the liver in chronically infected hepatitis C virus patients.

21 January 2018

1 reference

IL28B and PNPLA3 polymorphisms affect histological liver damage in patients with non-alcoholic fatty liver disease

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/JVH.12408

1 reference

30 September 2017

1 reference